首页 › 基金 › Blue Owl Capital Holdings LP › CABA

Blue Owl Capital Holdings LP 对 CABA 的持仓历史

CABALETTA BIO INC · 医疗保健

Blue Owl Capital Holdings LP 在 Q2 2026 的 13F 申报中披露持有 CABA(CABALETTA BIO INC)714,710 股,市值约 US$2.2M,约占其申报组合的 0.36%,在其申报持仓中市值排名第 28 位。 Blue Owl Capital Holdings LP 最近 5 个申报季度中有 2 个季度披露了 CABA 持仓,最早可追溯至 Q2 2025。

最新持仓 (Q2 2026)714.71K 股
申报持仓市值$2.22M
组合权重0.36%
首次申报Q2 2025
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Blue Owl Capital Holdings LP 对 CABA 的持仓演变

Blue Owl Capital Holdings LP 于 Q2 2025 首次披露 CABA 持仓:1,125,000 股(约 US$1.7M)。 该持仓在 Q2 2026 达到峰值 714,710 股,市值约 US$2.2M。 在 2 次申报中,Blue Owl Capital Holdings LP 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 714,710 股、市值约 US$2.2M。

逐季持仓明细

季度股数金额变化
Q2 2025 1.12M $1.71M 新进
Q2 2026 714.71K $2.22M 新进

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CABA 与 13F 数据

CABA(CABALETTA BIO INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 CABA,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CABA 的基金

查看 CABA 的全部基金持有人 →

常见问题

How long has Blue Owl Capital Holdings LP held CABA?

Blue Owl Capital Holdings LP has disclosed CABA holdings in 2 of the last 5 reported quarters, going back to Q2 2025.

What is Blue Owl Capital Holdings LP's current position in CABA?

As of Q2 2026, Blue Owl Capital Holdings LP holds 714.71K shares of CABA (CABALETTA BIO INC), valued at $2.22M, representing 0.36% of its reported portfolio and ranking #28.

Has Blue Owl Capital Holdings LP been buying or selling CABA?

In the latest 13F filing (Q2 2026), Blue Owl Capital Holdings LP newly opened its position in CABA. The position peaked in Q2 2026 at 714.71K shares.

Which other funds hold CABA?

Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.